Integrative profiling of neutrophil extracellular trap-related genes identifies ACTB as a promoter of pancreatic cancer aggressiveness

Background Pancreatic cancer (PC) is highly aggressive, and neutrophil extracellular traps (NETs) have been implicated in its progression. This study aimed to identify NET-related candidate genes associated with PC and investigate their functional significance. Methods Transcriptomic datasets from GEO and TCGA were integrated to identify NET-related differentially expressed genes. Machine-learning models, protein-protein interaction networks, and survival analyses were used to prioritize candidate genes. ACTB expression was evaluated using single-cell and spatial transcriptomics, immunohistochemistry (29 cancer and 27 normal tissues), and pancreatic cell lines. Single-cell comparisons were performed at the biological-sample level, with pseudobulk validation. ACTB function was assessed through overexpression and knockdown experiments and a mouse xenograft model. Serum dsDNA and blood NE/MPO mRNA levels were measured as NET-associated markers. Results Sixteen NET-related differentially expressed genes were identified. The optimal RF+plsRglm model achieved AUCs of 0.938, 0.877, and 0.836 in the training and two validation cohorts, respectively. ACTB emerged as a candidate hub gene and showed higher protein expression in pancreatic cancer tissues (P = 1.3 × 10 − ¹ 0 ). Exploratory Kaplan–Meier analysis suggested an association with survival, although continuous-expression Cox analysis was nonsignificant. In GSE212966, sample-level ACTB expression did not differ significantly between PDAC and adjacent non-tumor ductal/epithelial cells (P = 0.3095), consistent with pseudobulk analysis (FDR = 0.8898). Spatial transcriptomics revealed heterogeneous ACTB expression. ACTB overexpression promoted pancreatic cancer cell proliferation, migration, invasion, and xenograft growth, whereas knockdown suppressed malignant phenotypes in vitro . Increased serum dsDNA and blood NE/MPO mRNA levels accompanied ACTB overexpression in vivo . Conclusions ACTB is a NET-related candidate gene that promotes pancreatic cancer aggressiveness. Its association with increased NET-associated markers warrants further investigation, as direct regulation of NET formation remains unproven.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.1999604
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrative profiling of neutrophil extracellular trap-related genes identifies ACTB as a promoter of pancreatic cancer aggressiveness

Fengchun Lu, Bin Wu, Chundong Hu, Yiyu Shen
6 links
Frontiers in Immunology
Pancreatic and Hepatic Oncology Research
article

Integrative profiling of neutrophil extracellular trap-related genes identifies ACTB as a promoter of pancreatic cancer aggressiveness

Fengchun Lu, Bin Wu, Chundong Hu, Yiyu Shen
article en

Abstract

Background Pancreatic cancer (PC) is highly aggressive, and neutrophil extracellular traps (NETs) have been implicated in its progression. This study aimed to identify NET-related candidate genes associated with PC and investigate their functional significance. Methods Transcriptomic datasets from GEO and TCGA were integrated to identify NET-related differentially expressed genes. Machine-learning models, protein-protein interaction networks, and survival analyses were used to prioritize candidate genes. ACTB expression was evaluated using single-cell and spatial transcriptomics, immunohistochemistry (29 cancer and 27 normal tissues), and pancreatic cell lines. Single-cell comparisons were performed at the biological-sample level, with pseudobulk validation. ACTB function was assessed through overexpression and knockdown experiments and a mouse xenograft model. Serum dsDNA and blood NE/MPO mRNA levels were measured as NET-associated markers. Results Sixteen NET-related differentially expressed genes were identified. The optimal RF+plsRglm model achieved AUCs of 0.938, 0.877, and 0.836 in the training and two validation cohorts, respectively. ACTB emerged as a candidate hub gene and showed higher protein expression in pancreatic cancer tissues (P = 1.3 × 10 − ¹ 0 ). Exploratory Kaplan–Meier analysis suggested an association with survival, although continuous-expression Cox analysis was nonsignificant. In GSE212966, sample-level ACTB expression did not differ significantly between PDAC and adjacent non-tumor ductal/epithelial cells (P = 0.3095), consistent with pseudobulk analysis (FDR = 0.8898). Spatial transcriptomics revealed heterogeneous ACTB expression. ACTB overexpression promoted pancreatic cancer cell proliferation, migration, invasion, and xenograft growth, whereas knockdown suppressed malignant phenotypes in vitro . Increased serum dsDNA and blood NE/MPO mRNA levels accompanied ACTB overexpression in vivo . Conclusions ACTB is a NET-related candidate gene that promotes pancreatic cancer aggressiveness. Its association with increased NET-associated markers warrants further investigation, as direct regulation of NET formation remains unproven.

Frontiers in ImmunologyVol. 17
Jiaxing University (CN), Union Hospital (CN)
Medical Science and Technology Project of Zhejiang Province
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon